FDA Inspection 994257 — Sonoma Pharmaceuticals, Inc

Sonoma Pharmaceuticals, Inc — FEI 3004554409

The FDA completed an inspection of Sonoma Pharmaceuticals, Inc on Nov 2, 2016 in Boulder, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 2, 2016
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Boulder, CO (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.